Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A1EWVY8
Wed, 08.01.2025
Formycon AG
Press Release // January 8, 2025
Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®
Otulfi® approved by Health Canada for both subcutaneous and intravenous formulations to treat serious inflammatory diseases
Health Canada joins the FDA and the European Commission in gra [ … ]